(Q44665326)

English

Eradication of Helicobacter pylori by 7-day triple-therapy regimens combining pantoprazole with clarithromycin, metronidazole, or amoxicillin in patients with peptic ulcer disease: results of two double-blind, randomized studies

scientific article published in December 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Eradication of Helicobacter pylori by 7-day triple-therapy regimens combining pantoprazole with clarithromycin, metronidazole, or amoxicillin in patients with peptic ulcer disease: results of two double-blind, randomized studies (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Helicobacter pylori

1 reference

based on heuristic

inferred from title

eradication of infectious diseases

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

peptic ulcer disease

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Helicobacter pylori infectious disease

1 reference

based on heuristic

inferred from title

David Y. Graham

9

object named as

David Y Graham

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

author name string

Wieslaw J Bochenek

1

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Suzanne Peters

2

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Polly D Fraga

3

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Wenjin Wang

4

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Michael E Mack

5

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Michael S Osato

6

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Hala M T El-Zimaity

7

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Kelly D Davis

8

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Helicobacter pylori Pantoprazole Eradication (HELPPE) Study Group

10

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

publication date

1 December 2003

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

626-642

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus Report

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2003.00179.X

21 January 2018

Prevalence and demographic determinants of metronidazole resistance by Helicobacter pylori in a large cosmopolitan cohort of Australian dyspeptic patients.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2003.00179.X

21 January 2018

Primary resistance to clarithromycin in clinical strains of Helicobacter pylori isolated from children in Poland

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2003.00179.X

21 January 2018

Metronidazole resistance in Helicobacter pylori is due to null mutations in a gene (rdxA) that encodes an oxygen-insensitive NADPH nitroreductase

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2003.00179.X

21 January 2018

Antibiotic resistance mechanisms of Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2003.00179.X

21 January 2018

Clarithromycin resistance, but not CYP2C-19 polymorphism, has a major impact on treatment success in 7-day treatment regimen for cure of H. pylori infection: a multiple logistic regression analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2003.00179.X

21 January 2018

Evaluation of clarithromycin resistance and cagA and vacA genotyping of Helicobacter pylori strains from the west of Ireland using line probe assays

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2003.00179.X

21 January 2018

Pathophysiology of antibiotic resistance: clarithromycin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2003.00179.X

21 January 2018

Accurate prediction of macrolide resistance in Helicobacter pylori by a PCR line probe assay for detection of mutations in the 23S rRNA gene: multicenter validation study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2003.00179.X

21 January 2018

Clarithromycin-susceptible and -resistant Helicobacter pylori isolates with identical randomly amplified polymorphic DNA-PCR genotypes cultured from single gastric biopsy specimens prior to antibiotic therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2003.00179.X

21 January 2018

Risk factors for Helicobacter pylori resistance in the United States: the surveillance of H. pylori antimicrobial resistance partnership (SHARP) study, 1993-1999.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2003.00179.X

21 January 2018

Pattern of primary resistance of Helicobacter pylori to metronidazole or clarithromycin in the United States

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2003.00179.X

21 January 2018

A multicentre study on eradication of Helicobacter pylori using four 1-week triple therapies in China

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2003.00179.X

21 January 2018

Two new treatment regimens for Helicobacter pylori eradication: a randomised study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2003.00179.X

21 January 2018

The importance of clarithromycin dose in the management of Helicobacter pylori infection: a meta-analysis of triple therapies with a proton pump inhibitor, clarithromycin and amoxycillin or metronidazole.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2003.00179.X

21 January 2018

Triple therapy for Helicobacter pylori eradication: a comparison of pantoprazole once versus twice daily.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2003.00179.X

21 January 2018

Pantoprazole, azithromycin and tinidazole: short duration triple therapy for eradication of Helicobacter pylori infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2003.00179.X

21 January 2018

Eradication of H. pylori with pantoprazole, clarithromycin, and metronidazole in duodenal ulcer patients: a head-to-head comparison between two regimens of different duration

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2003.00179.X

21 January 2018

Comparative treatment of Helicobacter pylori-positive duodenal ulcer using pantoprazole at low and high doses versus omeprazole in triple therapy.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2003.00179.X

21 January 2018

Cure of Helicobacter pylori infection and healing of duodenal ulcer: comparison of pantoprazole-based one-week modified triple therapy versus two-week dual therapy. The International Pantoprazole HP Study Group.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2003.00179.X

21 January 2018

Cure of H. pylori infection using a 7-day triple therapy combining pantoprazole with two antibiotics.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2003.00179.X

21 January 2018

Pantoprazole-based 10-day triple therapy is effective in Helicobacter pylori eradication.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2003.00179.X

21 January 2018

Short-term low-dose pantoprazole-based triple therapy for cure of Helicobacter pylori infection in duodenal ulcer patients.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2003.00179.X

21 January 2018

Cure of Helicobacter pylori infection in elderly patients: comparison of low versus high doses of clarithromycin in combination with amoxicillin and pantoprazole

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2003.00179.X

21 January 2018

Lansoprazole triple therapy for Helicobacter pylori--is 5 days enough?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2003.00179.X

21 January 2018

Eradication of Helicobacter pylori with pantoprazole and two antibiotics: a comparison of two short-term regimens

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2003.00179.X

21 January 2018

A multicenter, double-blind study on triple therapy with lansoprazole, amoxicillin and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2003.00179.X

21 January 2018

Proton pump inhibitor, clarithromycin and either amoxycillin or nitroimidazole: a meta-analysis of eradication of Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2003.00179.X

21 January 2018

Comparison of two 1-week low-dose omeprazole triple therapies--optimal treatment for Helicobacter pylori infection?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2003.00179.X

21 January 2018

Triple therapy with clarithromycin, omeprazole, and amoxicillin for eradication of Helicobacter pylori in duodenal ulcer patients in Asia and Africa

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2003.00179.X

21 January 2018

Twice-daily, 10-day triple therapy with omeprazole, amoxicillin, and clarithromycin for Helicobacter pylori eradication in duodenal ulcer disease: results of three multicenter, double-blind, United States trials

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2003.00179.X

21 January 2018

Single vs. double dose of a proton pump inhibitor in triple therapy for Helicobacter pylori eradication: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2003.00179.X

21 January 2018

Predictors of failure of Helicobacter pylori eradication with the standard 'Maastricht triple therapy'.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2003.00179.X

21 January 2018

Randomized study of two "rescue" therapies for Helicobacter pylori-infected patients after failure of standard triple therapies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2003.00179.X

21 January 2018

Efficacy of quadruple therapy with pantoprazole, bismuth, tetracycline and metronidazole as rescue treatment for Helicobacter pylori infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2003.00179.X

21 January 2018

Review article: Helicobacter pylori "rescue" regimen when proton pump inhibitor-based triple therapies fail.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2003.00179.X

21 January 2018

Treatment of antibiotic-resistant Helicobacter pylori.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2003.00179.X

21 January 2018

Incidence of secondary Helicobacter pylori resistance to antibiotics in treatment failures after 1-week proton pump inhibitor-based triple therapies: a prospective study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2003.00179.X

21 January 2018

Do some patients with Helicobacter pylori infection benefit from an extension to 2 weeks of a proton pump inhibitor-based triple eradication therapy?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2003.00179.X

21 January 2018

Helicobacter pylori eradication therapy is more effective in peptic ulcer than in non-ulcer dyspepsia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2003.00179.X

21 January 2018

Antibiotic resistance of Helicobacter pylori strains in Japanese children

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2003.00179.X

21 January 2018

Helicobacter pylori eradication with proton pump inhibitor-based triple therapies and re-treatment with ranitidine bismuth citrate-based triple therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2003.00179.X

21 January 2018

Identifiers

10.1111/J.1523-5378.2003.00179.X

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44665326&oldid=2031215716"